Current Transplantation Reports

, Volume 5, Issue 4, pp 365–368 | Cite as

Commentary: Peri-Transplant Bariatric Surgery

  • Renana Yemini
  • Andrei Keidar
  • Eviatar Nesher
  • Eytan MorEmail author
Invited Commentary


Morbid obesity often serves as a contraindication to organ transplantation. Furthermore, metabolic complications developed in the peri-operative period and long term after transplant are associated with high mortality. As bariatric surgery is an acceptable measure to treat morbid obesity, it may serve also the transplant population before and after transplant.Methods A review of the literature was done, combined with our own experience with bariatric surgery in kidney and liver transplant recipients before, during, and after transplantation.ResultsPreliminary data show that bariatric surgery seems to be feasible in morbidly obese patients in the setting of transplantation, though associated with high post-operative complication rate. Laparoscopic sleeve gastrectomy (LSG) and laparoscopic Roux-en-Y gastric bypass (LRYBG) are both effective in the kidney transplant population while LSG is the preferred approach for liver transplant patients.ConclusionsAlthough bariatric surgery in the transplant population is not yet extensively studied and is mostly reported in small series, it seems a useful approach for the treatment of morbid obesity in these high-risk patients. Comparative data regarding optimal timing and type of bariatric procedure and long-term results are warranted.


Peri-transplant Bariatric surgery Obesity Peri-operative complications 


Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


  1. 1.
    Zaydfudim V, Feurer ID, Moore DE, Wisawatapnimit P, Wright JK, Wright PC. The negative effect of pretransplant overweight and obesity on the rate of improvement in physical quality of life after liver transplantation. Surgery. 2009;146(2):174–80. Scholar
  2. 2.
    Nair S, Cohen DB, Cohen MP, Tan H, Maley W, Thuluvath PJ. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol. 2001;96(3):842–5. Scholar
  3. 3.
    Mucha K, Foroncewicz B, Ryter M, et al. Weight gain in renal transplant recipients in a Polish single centre. Ann Transplant. 2015;20:16–20. Scholar
  4. 4.
    Beckmann S, Drent G, Ruppar T, De Geest S. Weight gain , overweight and obesity in solid organ transplantation — a study protocol for a systematic literature review. Syst Rev. 2015;4(2):1–8.Google Scholar
  5. 5.
    Richards J, Gunson B, Johnson J, Neuberger J. Weight gain and obesity after liver transplantation. Transpl Int. 2005;18(4):461–6. Scholar
  6. 6.
    Hoogeveen EK, Aalten J, Rothman KJ, Roodnat JI, Mallat MJK, Borm G, et al. Effect of obesity on the outcome of kidney transplantation: a 20-year follow-up. Transplantation. 2011;91(8):869–74. Scholar
  7. 7.
    Hawn MT, Bian J, Leeth RR, Ritchie G, Allen N, Bland KI, et al. Impact of obesity on resource utilization for general surgical procedures. Ann Surg. 2005;241(5):821–8. Scholar
  8. 8.
    Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, et al. Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies. Lancet. 2006;368(9536):666–78. Scholar
  9. 9.
    Gore JL, Pham PT, Danovitch GM, Wilkinson AH, Rosenthal JT, Lipshutz GS, et al. Obesity and outcome following renal transplantation. Am J Transplant. 2006;6(2):357–63. Scholar
  10. 10.
    Aalten J, Christiaans MH, De Fijter H, et al. The influence of obesity on short- and long-term graft and patient survival after renal transplantation. Transpl Int. 2006;19(11):901–7. Scholar
  11. 11.
    Meier-Kriesche H, Arndorfer J, Kaplan B. The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation. 2002;73(1):70–4 Scholar
  12. 12.
    Lynch RJ, Ranney DN, Shijie C, Lee DS, Samala N, Englesbe MJ. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg. 2009;250(6):1014–20. Scholar
  13. 13.
    Levin NW, Handelman GJ, Coresh J, Port FK, Kaysen GA. Reverse epidemiology: a confusing, confounding, and inaccurate term. Semin Dial. 2007;20(6):586–92. Scholar
  14. 14.
    Yemini R, Nesher E, Winkler J, Carmeli I, Azran C, Ben David M, Mor E, Keidar A Bariatric surgery in solid organ transplant patients: long-term follow-up results of outcome, safety, and effect on immunosuppression. Am J Transplant 2018.Google Scholar
  15. 15.
    Golomb I, Winkler J, Ben-Yakov A, Benitez CC, Keidar A. Laparoscopic sleeve gastrectomy as a weight reduction strategy in obese patients after kidney transplantation. Am J Transplant. 2014;14(10):2384–90. Scholar
  16. 16.
    Nesher E, Mor E, Shlomai A, et al. Simultaneous liver transplantation and sleeve gastrectomy: prohibitive combination or a necessity? Obes Surg. 2017;27(5).
  17. 17.
    Heimbach JK, Watt KDS, Poterucha JJ, Ziller NF, Cecco SD, Charlton MR, et al. Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end-stage liver disease. Am J Transplant. 2013;13(2):363–8. Scholar
  18. 18.
    Tichansky DS, Madan AK. Laparoscopic Roux-en-Y gastric bypass is safe and feasible after orthotopic liver transplantation. Obes Surg. 2005;15(10):1481–6. Scholar
  19. 19.
    Lin MYC, Tavakol MM, Sarin A, Amirkiai SM, Rogers SJ, Carter JT, et al. Safety and feasibility of sleeve gastrectomy in morbidly obese patients following liver transplantation. Surg Endosc Other Interv Tech. 2013;27(1):81–5. Scholar
  20. 20.
    Acosta A, Streett S, Kroh MD, et al. White paper AGA: POWER — practice guide on obesity and weight management, education, and resources. Clin Gastroenterol Hepatol. 2017;15(5):631–49.e10. Scholar
  21. 21.
    Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease—meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73–84. Scholar
  22. 22.
    Adams LA, Lymp JF, St. Sauver J, Sanderson SO, Lindor KD, Feldstein A, et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology. 2005;129(1):113–21. Scholar
  23. 23.
    Ludwig J, Viggiano TR, McGill DB, Oh BJ. Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc. 1980;55(7):434–8 Scholar
  24. 24.
    Hagström H, Nasr P, Ekstedt M, Hammar U, Stål P, Hultcrantz R, et al. Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study. Hepatol Commun. 2018;2(1):48–57. Scholar
  25. 25.
    Younossi Z, Stepanova M, Ong JP, Jacobson IM, Bugianesi E, Duseja A, et al. Non-alcoholic steatohepatitis is the fastest growing cause of hepatocellular carcinoma in liver transplant candidates. Clin Gastroenterol Hepatol. 2018.
  26. 26.
    Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA, Younossi ZM, et al. Nonalcoholic steatohepatitis is the second leading etiology of liver disease among adults awaiting liver transplantation in the United States. Gastroenterology. 2015;148(3):547–55. Scholar
  27. 27.
    Takata MC, Campos GM, Ciovica R, Rabl C, Rogers SJ, Cello JP, et al. Laparoscopic bariatric surgery improves candidacy in morbidly obese patients awaiting transplantation. Surg Obes Relat Dis. 2008;4(2):159–64. Scholar
  28. 28.
    Wu R, Ortiz J, Dallal R. Is bariatric surgery safe in cirrhotics? Hepat Mon. 2013;13(2):3–5. Scholar
  29. 29.
    Csikesz NG, Nguyen LN, Tseng JF, Shah SA. Nationwide volume and mortality after elective surgery in cirrhotic patients. J Am Coll Surg. 2009;208(1):96–103. Scholar
  30. 30.
    Campsen J, Zimmerman M, Shoen J, Wachs M, Bak T, Mandell MS, et al. Adjustable gastric banding in a morbidly obese patient during liver transplantation. Obes Surg. 2008;18(12):1625–7. Scholar
  31. 31.
    Lazzati A, Iannelli A, Schneck A, Nelson AC, Katsahian S, Gugenheim J. Bariatric surgery and liver transplantation : a systematic review a new frontier for bariatric surgery 2015:134–142. doi:, 25.
  32. 32.
    Sarkhosh K, Birch DW, Sharma A, Karmali S. Complications associated with laparoscopic sleeve gastrectomy for morbid obesity: a surgeon’s guide. Can J Surg. 2013;56(5):347–52. Scholar
  33. 33.
    Osseis M, Lazzati A, Salloum C, Gavara CG, Compagnon P, Feray C, et al. Sleeve gastrectomy after liver transplantation: feasibility and outcomes. Obes Surg. 2018;28(1):242–8. Scholar
  34. 34.
    Shimizu H, Phuong V, Maia M, Kroh M, Chand B, Schauer PR, et al. Bariatric surgery in patients with liver cirrhosis. Surg Obes Relat Dis. 2013;9(1):1–6. Scholar
  35. 35.
    Schauer PR, Kashyap SR, Wolski K, Brethauer SA, Kirwan JP, Pothier CE, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366(17):1567–76. Scholar
  36. 36.
    Sjöström L, Lindroos A-K, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683–93. Scholar
  37. 37.
    Suraweera D, Dutson E, Saab S. Liver transplantation and bariatric surgery: best approach. Clin Liver Dis. 2017;21(2):215–30. Scholar
  38. 38.
    Tsochatzis E, Coilly A, Nadalin S, et al. International Liver Transplantation Consensus Statement on End-Stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.; 2018. doi:, International Liver Transplantation Consensus Statement on end-stage liver disease due to nonalcoholic steatohepatitis and liver transplantation.
  39. 39.
    Diwan T, Heimbac J, Schauer D. Liver transplantation and bariatric surgery: timing and outcomes. Liver Transplant. 2018:1–38.
  40. 40.
    Zamora-Valdes D, Watt KD, Kellogg TA, Poterucha JJ, di Cecco SR, Francisco-Ziller NM, et al. Long-term outcomes of patients undergoing simultaneous liver transplantation and sleeve gastrectomy. Hepatology. 2018;68(2):485–95. Scholar
  41. 41.
    Padwal R, Brocks D, Sharma AM. A systematic review of drug absorption following bariatric surgery and its theoretical implications. Obes Rev. 2010;11(1):41–50. Scholar
  42. 42.
    Nishi K, Ishii T, Wada M, et al. The colon displays an absorptive capacity of tacrolimus. In: Transplantation Proceedings.Vol 36.; 2004:364–366. doi:

Copyright information

© Springer Nature Switzerland AG 2018

Authors and Affiliations

  • Renana Yemini
    • 1
    • 2
    • 3
  • Andrei Keidar
    • 2
    • 3
  • Eviatar Nesher
    • 1
  • Eytan Mor
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of Transplant Surgery, Beilinson Medical Center, Petach-Tikva, Israel, affiliated to the Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael
  2. 2.Department of Surgery, Assuta Ashdod Hospital, Ashdod, Israel, affiliated to Ben-Gurion UniversityBeer-ShevaIsrael
  3. 3.Department of Surgery, Bariatric Clinic, Rabin Medical Center, Beilinson Hospital, Petach-Tikva, Israel, affiliated to the Sackler Faculty of MedicineTel-Aviv UniversityTel-AvivIsrael

Personalised recommendations